Patent · US Active

Ready-to-use tranexamic acid intravenous solution

US11696905B2 · kind B2 · utility

0Cited by
16References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 16, 2021
Grant dateJul 11, 2023
Priority date
Expiry dateSep 2, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P7/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Ready-to-use, stable aqueous intravenous tranexamic acid compositions are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.